Sionna Therapeutics Statistics
NASDAQ: SIONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.83-0.145 (-4.88%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Sionna Therapeutics by the numbers
Sionna Therapeutics has a market capitalization of $127.8 million based on 45.24M shares outstanding. With trailing EPS of $-2.43, Sionna Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.8% below its 50-day average and 89.6% below its 200-day average.
Average daily trading volume is 1.12M shares, or about $3.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SION valuation vs. peer median
| Metric | SION | Peer median | Difference |
|---|---|---|---|
| Market cap | $127.79M | $122.89M | +4% |
| Avg. volume | 1.12M | 490.19K | +129% |
Peer median across 8 companies: MGNX, ZNTL, MSLE, ALXO, ADAG, OKUR, IMUX, BBOT.
Valuation
- Market cap
- $127.79M
- EPS (TTM)
- $-2.43
- Shares outstanding
- 45.24M
Price and trading
- Previous close
- 2.97
- Open
- 2.93
- Day range
- 2.76 – 3.06
- 52-week range
- 2.75 – 54.97
- 52-week change
- -93.53%
- Beta
- —
- Volume
- 547.66K
- Average volume
- 1.12M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 127.79M
- Forward Pe
- -1.23
- Eps
- -2.43
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 54.97
- Week52 Low
- 2.75
- Avg Volume
- 1.12M
- Shares Outstanding
- 45.24M
- Ma50
- 4.47
- Ma200
- 27.26
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -94.86%
- Pct From52w Low
- 2.58%